BOLT 8-K 2026-10-23

Bolt Biotherapeutics, Inc. (BOLT) 8-K dated 2026-10-23 — accession 0001193125-26-429647. This URL is the filing, not the BOLT hub.

Bolt Biotherapeutics, Inc. (BOLT) is a biotechnology company listed on US.

Bolt Biotherapeutics, Inc. filed a 8-K on 2026-10-23. Accession 0001193125-26-429647.

Cached items: 1.01, 1.02, 2.01, 3.02, 5.02, 5.03. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported BOLT revenue for 2025-12-31 was $7.7M. Net income was -$33.4M. Revenue was up 0.1% from 2024-12-31 to 2025-12-31. BOLT currently screens at market cap $11.3M.

Not investment advice. The BOLT SEC hub lists recent forms. The stock page is the research view.